Biotech FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa August 19, 2022
Biotech SpringWorks Therapeutics Announces Late-Breaking Oral Presentation of Phase 3 DeFi Data at the European Society for Medical Oncology (ESMO) Congress 2022 August 19, 2022
Biotech BridgeBio Pharma Announces Dosing of First Patient in Phase 1 Trial of BBP-671, a Potential Best-In-Class Treatment for Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA) August 18, 2022
Biotech NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results August 18, 2022
Biotech Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 18, 2022
Biotech Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs Global Sustainability Forum August 18, 2022
Biotech Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344 August 9, 2022